Literature DB >> 30378472

Joint longitudinal and time-to-event models for multilevel hierarchical data.

Samuel L Brilleman1,2, Michael J Crowther3, Margarita Moreno-Betancur2,4,5, Jacqueline Buros Novik6, James Dunyak7, Nidal Al-Huniti7, Robert Fox7, Jeff Hammerbacher6,8, Rory Wolfe1,2.   

Abstract

Joint modelling of longitudinal and time-to-event data has received much attention recently. Increasingly, extensions to standard joint modelling approaches are being proposed to handle complex data structures commonly encountered in applied research. In this paper, we propose a joint model for hierarchical longitudinal and time-to-event data. Our motivating application explores the association between tumor burden and progression-free survival in non-small cell lung cancer patients. We define tumor burden as a function of the sizes of target lesions clustered within a patient. Since a patient may have more than one lesion, and each lesion is tracked over time, the data have a three-level hierarchical structure: repeated measurements taken at time points (level 1) clustered within lesions (level 2) within patients (level 3). We jointly model the lesion-specific longitudinal trajectories and patient-specific risk of death or disease progression by specifying novel association structures that combine information across lower level clusters (e.g. lesions) into patient-level summaries (e.g. tumor burden). We provide user-friendly software for fitting the model under a Bayesian framework. Lastly, we discuss alternative situations in which additional clustering factor(s) occur at a level higher in the hierarchy than the patient-level, since this has implications for the model formulation.

Entities:  

Keywords:  Longitudinal; cancer; hierarchical; joint model; multilevel; shared parameter model; survival

Mesh:

Year:  2018        PMID: 30378472     DOI: 10.1177/0962280218808821

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  7 in total

1.  Bayesian joint modelling of longitudinal and time to event data: a methodological review.

Authors:  Maha Alsefri; Maria Sudell; Marta García-Fiñana; Ruwanthi Kolamunnage-Dona
Journal:  BMC Med Res Methodol       Date:  2020-04-26       Impact factor: 4.615

Review 2.  Tumor Growth Dynamic Modeling in Oncology Drug Development and Regulatory Approval: Past, Present, and Future Opportunities.

Authors:  Nidal Al-Huniti; Yan Feng; Jingyu Jerry Yu; Zheng Lu; Mario Nagase; Diansong Zhou; Jennifer Sheng
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2020-07-22

3.  Modeling Tumor Growth and Treatment Resistance Dynamics Characterizes Different Response to Gefitinib or Chemotherapy in Non-Small Cell Lung Cancer.

Authors:  Mario Nagase; Sergey Aksenov; Hong Yan; James Dunyak; Nidal Al-Huniti
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2020-02-07

4.  Longitudinal Tumor Size and Neutrophil-to-Lymphocyte Ratio Are Prognostic Biomarkers for Overall Survival in Patients With Advanced Non-Small Cell Lung Cancer Treated With Durvalumab.

Authors:  Sergey Gavrilov; Kirill Zhudenkov; Gabriel Helmlinger; James Dunyak; Kirill Peskov; Sergey Aksenov
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2020-12-21

5.  Glucocorticoid exposure predicts survival in female baboons.

Authors:  Fernando A Campos; Elizabeth A Archie; Laurence R Gesquiere; Jenny Tung; Jeanne Altmann; Susan C Alberts
Journal:  Sci Adv       Date:  2021-04-21       Impact factor: 14.136

6.  Susceptibility status of the wild-caught Phlebotomus argentipes (Diptera: Psychodidae: Phlebotominae), the sand fly vector of visceral leishmaniasis, to different insecticides in Nepal.

Authors:  Lalita Roy; Surendra Uranw; Kristien Cloots; Tom Smekens; Usha Kiran; Uttam Raj Pyakurel; Murari Lal Das; Rajpal S Yadav; Wim Van Bortel
Journal:  PLoS Negl Trop Dis       Date:  2022-07-14

Review 7.  Individual participant data meta-analysis of intervention studies with time-to-event outcomes: A review of the methodology and an applied example.

Authors:  Valentijn M T de Jong; Karel G M Moons; Richard D Riley; Catrin Tudur Smith; Anthony G Marson; Marinus J C Eijkemans; Thomas P A Debray
Journal:  Res Synth Methods       Date:  2020-02-06       Impact factor: 5.273

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.